Renshall, L.J.; Beards, F.; Evangelinos, A.; Greenwood, S.L.; Brownbill, P.; Stevens, A.; Sibley, C.P.; Aplin, J.D.; Johnstone, E.D.; Teesalu, T.;
et al. Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction. Pharmaceutics 2021, 13, 1778.
https://doi.org/10.3390/pharmaceutics13111778
AMA Style
Renshall LJ, Beards F, Evangelinos A, Greenwood SL, Brownbill P, Stevens A, Sibley CP, Aplin JD, Johnstone ED, Teesalu T,
et al. Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction. Pharmaceutics. 2021; 13(11):1778.
https://doi.org/10.3390/pharmaceutics13111778
Chicago/Turabian Style
Renshall, Lewis J., Frances Beards, Angelos Evangelinos, Susan L. Greenwood, Paul Brownbill, Adam Stevens, Colin P. Sibley, John D. Aplin, Edward D. Johnstone, Tambet Teesalu,
and et al. 2021. "Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction" Pharmaceutics 13, no. 11: 1778.
https://doi.org/10.3390/pharmaceutics13111778
APA Style
Renshall, L. J., Beards, F., Evangelinos, A., Greenwood, S. L., Brownbill, P., Stevens, A., Sibley, C. P., Aplin, J. D., Johnstone, E. D., Teesalu, T., & Harris, L. K.
(2021). Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction. Pharmaceutics, 13(11), 1778.
https://doi.org/10.3390/pharmaceutics13111778
